Latest News and Press Releases

Newark, New Castle, USA, March 22, 2023 (GLOBE NEWSWIRE) -- The global circulating tumor cell (CTC) diagnostics market will be valued at US$ 23.85 billion by 2030 owing to rising prevalence of...

Approval extends Evkeeza to children aged 5 to 11 with homozygous familial hypercholesterolemia (HoFH), an inherited condition characterized by extremely high low-density lipoprotein cholesterol...

- 44mg Q2W dose had a placebo-adjusted effect size of 20% on at least one-stage fibrosis improvement without worsening of NASH (p=0.008) and 24% on NASH resolution without worsening of fibrosis...

Barranquilla, Colombia, March 22, 2023 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE : TGLS) ("Tecnoglass" or the "Company"), a leading manufacturer of architectural glass, windows, and associated...

Revenue Grows 160% to $178.7 Million in Fiscal Year 2022 Reiterates 2023 Guidance Conference Call today, March 22, at 8:30 a.m. ET FORT LAUDERDALE, Fla., March 22, 2023 (GLOBE NEWSWIRE) --...

AUSTIN, Texas, March 22, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced...

WATERTOWN, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment...

-- Continued Growth in Marine, with Revenues Up 16% -- -- Sustained Double-Digit Margins Across All Segments -- -- Diversified Outdoor Portfolio Continues to Support Profitability and Resiliency -- ...

TORONTO, March 22, 2023 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), an internationally regulated sports betting and media company, today...

Project follows successful View installation in Phase I of Concourse A expansion, enhancing experience for passengers at one of nation’s busiest airports MILPITAS, Calif. and CHARLOTTE, N.C., March...